Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative
- PMID: 37276136
- PMCID: PMC10564559
- DOI: 10.1037/neu0000888
Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative
Abstract
Objective: Self-perceived cognitive functioning, considered highly relevant in the context of aging and dementia, is assessed in numerous ways-hindering the comparison of findings across studies and settings. Therefore, the present study aimed to link item-level self-report questionnaire data from international aging studies.
Method: We harmonized secondary data from 24 studies and 40 different questionnaires with item response theory (IRT) techniques using a graded response model with a Bayesian estimator. We compared item information curves to identify items with high measurement precision at different levels of the self-perceived cognitive functioning latent trait. Data from 53,030 neuropsychologically intact older adults were included, from 13 English language and 11 non-English (or mixed) language studies.
Results: We successfully linked all questionnaires and demonstrated that a single-factor structure was reasonable for the latent trait. Items that made the greatest contribution to measurement precision (i.e., "top items") assessed general and specific memory problems and aspects of executive functioning, attention, language, calculation, and visuospatial skills. These top items originated from distinct questionnaires and varied in format, range, time frames, response options, and whether they captured ability and/or change.
Conclusions: This was the first study to calibrate self-perceived cognitive functioning data of geographically diverse older adults. The resulting item scores are on the same metric, facilitating joint or pooled analyses across international studies. Results may lead to the development of new self-perceived cognitive functioning questionnaires guided by psychometric properties, content, and other important features of items in our item bank. (PsycInfo Database Record (c) 2023 APA, all rights reserved).
Conflict of interest statement
Conflict of Interest
SCJ serves on an advisory boards to Roche Diagnostics, Prothena, and Eisai in the past two years and has received research support from Cerveau Technologies. JLM is a full time employee at H. Lundbeck A/S. RCP is a consultant for Roche, Inc., Merck, Inc., Biogen, Inc., Genentech, Inc., Eisai, Inc., and Nestle, Inc. PSS was a Member of Advisory Committees for Biogen Australia and Roche Australia in 2020 and 2021. AJS receives support from multiple NIH grants (P30 AG010133, P30 AG072976, R01 AG019771, R01 AG057739, U19 AG024904, R01 LM013463, R01 AG068193, T32 AG071444, and U01 AG068057 and U01 AG072177). He has also received support from Avid Radiopharmaceuticals, a subsidiary of Eli Lilly (in kind contribution of PET tracer precursor); Bayer Oncology (Scientific Advisory Board); Eisai (Scientific Advisory Board); Siemens Medical Solutions USA, Inc. (Dementia Advisory Board); NIH NHLBI (MESA Observational Study Monitoring Board); Springer-Nature Publishing (Editorial Office Support as Editor-in-Chief, Brain Imaging and Behavior). NS is Chair of the Data Safety Monitoring Board for an NIH funded study at The Albert Einstein College of Medicine. NS is also a local site PI of a phase III industry sponsored study (Semaglutide - Novonordisc), with funding to the Institution.
Figures
References
-
- Amariglio RE, Donohue MC, Marshall GA, Rentz DM, Salmon DP, Ferris SH, … & Sperling RA (2015a). Tracking early decline in cognitive function in older individuals at risk for Alzheimer disease dementia: the Alzheimer’s Disease Cooperative Study Cognitive Function Instrument. JAMA Neurology, 72(4), 446–454. doi:10.1001/jamaneurol.2014.3375 - DOI - PMC - PubMed
MeSH terms
Grants and funding
- T32 AG071444/AG/NIA NIH HHS/United States
- U01 AG024904/AG/NIA NIH HHS/United States
- U01 AG068057/AG/NIA NIH HHS/United States
- U19 AG024904/AG/NIA NIH HHS/United States
- R01 AG080635/AG/NIA NIH HHS/United States
- NH/NIH HHS/United States
- R01 AG034962/AG/NIA NIH HHS/United States
- R01 LM013463/LM/NLM NIH HHS/United States
- SC2 AG039235/AG/NIA NIH HHS/United States
- R01 AG019771/AG/NIA NIH HHS/United States
- U01 AG072177/AG/NIA NIH HHS/United States
- P30 AG010133/AG/NIA NIH HHS/United States
- ALZ/Alzheimer's Association/United States
- R15 AG066039/AG/NIA NIH HHS/United States
- R01 AG057739/AG/NIA NIH HHS/United States
- R01 AG068193/AG/NIA NIH HHS/United States
- P01 AG003949/AG/NIA NIH HHS/United States
- P30 AG072976/AG/NIA NIH HHS/United States
